Medtronic Activa Approvable With Conditions; Data Show Dyskinesia Drop Off

Medtronic's Activa Parkinson's control therapy system should be indicated for treatment only of "advanced levadopa (L-dopa) responsive" Parkinson's patients, FDA's Neurological Devices Panel recommended at a March 31 meeting in Rockville, Maryland.